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There are various methods for detection of Helicobacter pylori and the gold standard for non-invasive detection is
the urea breath test (UBT). The aim of the study is therefore to detect H. pylori from the stool of patients with
dyspepsia by PCR and compare results obtained with UBT. A total of 97 stool samples from patients presenting
with dyspeptic symptoms in Lagos University Teaching Hospital (LUTH) were screened for urea breath test (UBT)
and the presence of H. pylori DNA using stool-PCR. Out of 97 stool samples analysed, 38 (39.2%) were positive for
Helicobacter spp. and 20 (20.6%) positive for H. pylori by PCR, through amplification of 16S rRNA and glmM genes
respectively. Of the 20 positive by glmM gene, the cagA gene was detected in 8 (40%) samples, while 47 (48.5%)
out of 97 stool samples were positive for H. pylori by UBT. The sensitivity and specificity of the glmM gene
compared with UBT as the gold standard is 42.6% and 100% respectively. The positive predictive value (PPV) was
100% while the negative predictive value (NPV) was 60%.The method may be useful for detecting H. pylori from
stool amongst children especially where most hospitals lack endoscope for children although the method is
expensive.
Keywords: UBT, Stool-PCR, Helicobacter pylori, NigeriaIntroduction
Helicobacter pylori is the causative agent of gastritis,
peptic ulcer disease (PUD), MALT lymphoma and a risk
factor in the development of gastric cancer (Blaser and
Berg 2001). It has also been classified as a class I car-
cinogen by the International Agency for Research on
Cancer (IARC) Monogr Eval Carcinog Risks Hum 1994
(an arm of WHO) in 1994. The mode of transmission
still unknown, although epidemiologic studies suggest
close person to person contact, intrafamilial spread.
There is still uncertainty whether transmission occurs
primarily through faecal-oral or gastric-oral route (Cov-
acci et al., 1999). There are various tests for H. pylori
diagnoses broadly categorized into two: invasive and
non-invasive (Mégraud and Lehours 2007). Invasive
methods require endoscopy while the non-invasive* Correspondence: stellaismith@yahoo.com
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in any medium, provided the original work is pmethods do not. The invasive methods include culture
(which is the gold standard), Rapid urease tests (RUT),
histology, direct gram stain, PCR based methods and
fluorescence in situ hybridization (FISH). The non-
invasive methods include serology (which does not
measure active infection), urea breath tests (UBT) (both
13C and 14C, gold standard, which is an expensive test
and cannot be available in routine clinical laboratories),
Helicobacter pylori stool antigen tests (HpSA) (Mégraud
and Lehours 2007).
Helicobacter pylori can be detected in stool specimens
either by culture (difficult due to diverse microorganisms
in the stool and fastidious nature of H. pylori), HpSA
(discrepancies also occur from one geographical area to
the other) and stool-PCR (with success rates of 25%–
100%). Generally, the differences in detection rate of H.
pylori in stool is due to H. pylori degradation in the
gastrointestinal tract and/or presence of inhibitors such
as complex polysaccharides and also its presence in low
concentration in stools (Kabir 2001).n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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organism directly in different clinical specimens. Various
authors have reported on the use of stool-PCR for diag-
nosis of H. pylori (Şen et al. 2005; Hirai et al. 2009;
Aktepe et al. 2011). The sensitivity with this method in
recent times has varied from 21%–65.22% (Aktepe et al.
2011; Şen et al. 2005). However non-invasive methods
that give accurate results are sought after. The study is
therefore aimed at detecting H. pylori in stools of
patients with dyspepsia using stool-PCR.
Materials and methods
Study period: August 2009–April 2010.
Ethical approval was obtained from NIMR-IRB, while
informed consent was obtained from patients before
stool samples were taken.
Inclusion Criteria: patients not on antibiotics or
PPI’s/histamine- 2- receptor blockers at least a month
before the study as well as presenting with dyspepsia
symptoms.
Exclusion Criteria: those currently on antibiotics and
or PPI’s/histamine 2 receptor blockers.
Clinical samples
Sampling method: Convenient sampling. Stool samples
from 97 dyspeptic patients at the LUTH were used for
this study. The stool samples were collected using sterile
toothpicks into eppendorf tubes containing 700 μl abso-
lute ethanol at room temperature. The samples was con-
sidered H. pylori- positive when glmM gene or both
genes (glmM and cagA) were detected by PCR, and the
results compared with those from UBT as the gold
standard and confirmatory test.
UBT
To screen for UBT, H. pylori testing was performed
using a validated Heliprobe system (Noster AB Sweden).
The heliprobe UBT is a 14C-based urea breath test for
the detection of H. pylori infection. It comprises the
Helicap TM capsule which contains the 14C-labelled
urea which is swallowed and metabolized to carbon di-
oxide and ammonia by the urease enzyme produced by
H. pylori. Labeled 14 C exhaled in the breath is captured
by a breathcard and analysed by the automatic heliprobe
analyser. Levels above 50 counts/min were considered
positive of H. pylori infection.
Stool-PCR
16SrRNA gene (399 bp)
Briefly, DNA from the stool samples were purified using
the QIAampW DNA Stool Mini kit (Hilden, Germany)
containing an inhibitEX (removes all DNA damaging
substances and PCR inhibitors in stool), and detected
using a PCR assay targeting a 399 bp fragment of the16S rRNA gene of Helicobacter spp. with two specific
primers, HeliF (AAC GAT GAA GCT TCT AGC TTG
CTA G) and HeliR (GTG CTT ATT CST NAG ATA
CCG TCA T) (Germani et al. 1997). PCR was performed
using the Ready To-Go PCR beads kit by GE Health-
care (Buckinghamshire, UK). Amplification was carried
out in an Eppendorf Mastercycler gradient (Hamburg,
Germany) using the following cycling parameters: An
initial denaturation at 94°C for 5 min and 35 cycles of
94°C for 30 s, 56°C for 1 min and 72°C for 1 min. This
was followed by a final extension of 72°C for 10 min.
The PCR product was separated on a 2% Agarose gel
and 50 bp ladder was used as DNA molecular weight
standard.cagA gene (128 bp)
PCR amplification using this primer was carried out
using the primer set cagA-F : 50-ATAATGCTAAATTA
GACAACTTGAGCGA-30 and 50-AGAAACAAAAGCA
ATACGATCATTC-30 Rugge et al. (1999). The 25 μl re-
action mixture consisted of x1 PCR buffer, 1.5 mM Mag-
nesium Chloride, 200 μM of each dNTP, 20pmol of each
primer and 1U Taq DNA polymerase (Promega).
Amplification was carried out in an Eppendorf Master-
cycler gradient using the following cycling parameters:
an initial denaturation at 94°C for 5 min and 40 cycles
of 94°C for 1 min, 54°C for 1 min and 72°C for 1 min.
This was followed by a final extension of 72°C for 5 min.
The PCR product was separated on a 2% Agarose gel
and 50 bp ladder was used as DNA molecular weight
standard.glmM gene (294 bp)
The following primers were used: F : 50-GGATAA-
GCTTTTAGGGGTGTTAGGGG-30 (738–763) and R :
50-GCTTACTTTCTAACACTAACGCGC-30(1010–1033)
Kansau et al. (1996). The 25 μl reaction mixture con-
sisted of x1 PCR buffer, 1.5 mM Magnesium Chloride,
200 μM of each dNTP, 20pmol of each primer and
1U Taq DNA polymerase (Promega).
The following were the conditions for amplification:
one cycle of denaturation at 94°C × 5 min; 35 cycles at
94°C × 1 min, annealing at 56°C × 1 min, and elongation
at 72°C × 2 min, followed by a final elongation step by
1 cycle at 72°C × 7 min. 15°C and amplification was
carried out in an Eppendorf Master cycler gradient
(Hamburg). The PCR product was separated on a 2%
Agarose gel and 50 bp ladder was used as DNA molecu-
lar weight standard.
Sensitivity of the primers was determined by testing
other bacterial strains from related genus e.g. Salmonella
Typhimurium and E. coli. The results of the glmM gene
was compared with the gold standard (UBT) using the
Table 2 shows cagA + glmM genes with the subspecies,
Helicobacter spp. and H. pylori
Helicobacter spp. (16S rRNA) H. pylori
cagA+glmM 8 8
glmM 10 12
cagA, glmM - 20 -
Total 38 20
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sitivity and specificity.
The glmM and cagA genes are genes commonly used
for the diagnosis of H. pylori directly from biopsy speci-
mens as well as isolates and was therefore adapted for
use for stool PCR in this study.
Results
None of the Salmonella Typhimurium or E. coli ampli-
fied with the set of specific primers for 16S rRNA and
glmM genes.
Out of 97 stool samples analysed, Helicobacter spp.
and H. pylori DNA were detected in 38 (39.2%) and 20
(20.6%) by 16S rRNA and glmM genes respectively. The
detection of cagA positivity by PCR was observed in 8
out of 20 (40%) samples positive for glmM gene whereas
47 out of 97 (48.5%) samples were positive for H. pylori
by UBT (Table 1). Those simultaneously positive for
stool-PCR (glmM gene) and UBT were 20 (42.6%) while
27 (57.5%) were positive for UBT and negative for stool-
PCR using glmM gene. Table 2 shows the evidenced
genes (cagA and glmM) and the subspecies. The sensitiv-
ity and specificity of the glmM gene compared with UBT
as the gold standard is 42.6% and 100% respectively. The
positive predictive value (PPV) was 100% while the nega-
tive predictive value (NPV) was 60%.
Figure 1 and 2 shows the PCR amplification of the
samples using glmM and 16S rRNA genes respectively.
Discussion
Non-invasive tests can play an important role in the
diagnosis of H. pylori infections. However, all have their
limitations in terms of cost, specificity, and sensitivity.
The data presented here, are the results of a pilot study
that preceded a project encompassing for UBT and PCR
in monitoring a larger dyspeptic patient population. The
16S rRNA PCR amplified Helicobacter DNA (39%) in
stool samples, being the most widely used method for
detection of H. pylori in clinical specimens. However,
the glmM gene PCR is the most sensitive and specific
for the detection of H. pylori in gastric biopsy specimens
Lu et al. (1999). The presence of H. pylori DNA was
found in stool samples (21%). The results show that to
some extent the glmM gene for detection of H. pylori
DNA by PCR may be useful for the diagnosis of H. pyl-
ori from stool. In comparison with UBT as the goldTable 1 Results of stool PCR test using glmM gene with UBT a
Resu
Positive Negative Tot
UBT (n = 97) Positive 20 27 47
Negative 0 50 50
Total 20 77 97standard, the sensitivity and specificity was 42.6% and
100%, respectively. The sensitivity is low. In a related
study by Aktepe et al. (2011); using five methods of de-
tection of H. pylori, the stool-PCR had the lowest sensi-
tivity (21%). However, Makristathis et al. (1998)
developed a semi-nested PCR assay, targeted to a
species-specific protein antigen which is present in all
strains of H. pylori, for detection and follow-up of H.
pylori infected patients and the sensitivity was as high as
93.7% and the specificity was 100%. Another study by
Mishra et al. (2008) corroborated the high sensitivity of
stool-PCR in both pre-eradication and post-eradication
to be 72.5% and 97.1% and the authors concluded that
stool-PCR was better indicator than HpSA test in post-
eradication assessment of infection. Another report by
Gramley et al. (1999) reported sensitivity of stool-PCR
to be 73%.
In this study, cagA gene was present in 40% of the
samples positive for H. pylori by glmM gene and in a
related study by Bindayna et al. (2006), cagA gene was
found to be present in 22.7% this is lower than in our
study. cagA positive H. pylori strains have been asso-
ciated with severity of disease outcome and plays a crit-
ical role in the development of stomach cancer. From
our previous studies with gastric biopsy specimens, cagA
positive H. pylori was found in 68% of the biopsy speci-
mens (Smith et al. 2004); while from a related study by
Bindayna et al. (2006) 59% of the biopsy samples were
positive for cagA gene, when compared with 22.7% from
stool samples. It goes to show the low prevalence of
cagA gene in stool samples when compared to biopsy
samples and this could be attributable to low numbers
of H. pylori in stool samples as well as problems of fae-
cal PCR inhibitors although the Qiagen kit was used to
circumvent this in our study. In terms of high sensitivity
and specificity found in studies with stool PCR these
could be due to methods of DNA extraction as well ass the gold standard
lts for stool-PCR, glmM gene (n = 97)
al Sensitivity Specificity PPV NPV
42.60% 100% 100.00% 60.00%






Figure 1 Gel electrophoresis of PCR products amplified using the glmM gene for H. pylori. Lanes: M: molecular weight marker;
-: negative control, +: positive control; 1 – 7 samples.
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In addition, glmM and cagA genes have not been found
yet in Helicobacter spp. other than H. pylori, suggesting
that non-H. pylori helicobacters species may be com-
monly found in the stool of humans.
The PCR using H. pylori species specific primers in
the long run could be also useful especially when infants,
or very young children and patients with certain neuro-
logical disorders are being screened and UBT cannot
be convenient for them. The method is also convenient
for sample collection and samples can even be collected
at home.M 1 2 3 4
Figure 2 Gel electrophoresis of PCR products amplified using the 16S
marker; 1: positive control, 2: negative control; 3 – 12 samples.The method using the Qiagen stool mini kit is expen-
sive but inexpensive methods that could help remove
inhibitors in stool could be used to reduce cost e.g. fil-
teration of stool and column chromatography.
From our study this method is not suitable for routine
clinical setting in the developing countries but could be
restricted to Reference labs where issues bordering on
recurrent H. pylori infections and treatment failure are a
problem especially where culture is difficult due to
power outages in the developing countries. This study
did not look at very young children due to the conveni-
ent sampling method which was biased.5 6 7 8 9 10 11 12
rRNA gene of Helicobacter spp. Lanes: M: molecular weight
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our lab is as follows:
Advantages of stool-PCR
1) It is non-invasive
2) It can be used in children and most especially those
with neurological disorders.
3) It is useful for early screening in children to enable
prompt detection of H. pylori related infection and
aid in subsequent treatment.
4) It would capture the generality of children, especially
the under 10, as most hospitals don’t have child
endoscopes so it becomes difficult to screen children
thoroughly due to lack of child endoscopes.
Disadvantages
1) It is expensive for use in developing countries as
long as the qiagen kit is employed.
2) It might not be readily available in most diagnostic
labs as with other PCR related methods and so has
to be restricted to reference labs.
In conclusion, it could be most useful for diagnosis of
H. pylori in children especially as endoscope for children
is lacking.
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